Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 224

1.

Effect of renal artery revascularization upon cardiac structure and function in atherosclerotic renal artery stenosis: cardiac magnetic resonance sub-study of the ASTRAL trial.

Ritchie J, Green D, Chrysochou T, Hegarty J, Handley K, Ives N, Wheatley K, Houston G, Wright J, Neyses L, Chalmers N, Mark P, Patel R, Moss J, Roditi G, Eadington D, Lukaschuk E, Cleland J, Kalra PA.

Nephrol Dial Transplant. 2016 Jun 2. pii: gfw107. [Epub ahead of print]

PMID:
27257278
2.

Bortezomib for the treatment of multiple myeloma.

Scott K, Hayden PJ, Will A, Wheatley K, Coyne I.

Cochrane Database Syst Rev. 2016 Apr 20;4:CD010816. doi: 10.1002/14651858.CD010816.pub2. Review.

PMID:
27096326
3.

An Occupational Therapy intervention for residents with stroke-related disabilities in UK Care Homes (OTCH): cluster randomised controlled trial with economic evaluation.

Sackley CM, Walker MF, Burton CR, Watkins CL, Mant J, Roalfe AK, Wheatley K, Sheehan B, Sharp L, Stant KE, Fletcher-Smith J, Steel K, Barton GR, Irvine L, Peryer G.

Health Technol Assess. 2016 Feb;20(15):1-138. doi: 10.3310/hta20150.

4.

Dive characteristics can predict foraging success in Australian fur seals (Arctocephalus pusillus doriferus) as validated by animal-borne video.

Volpov BL, Rosen DA, Hoskins AJ, Lourie HJ, Dorville N, Baylis AM, Wheatley KE, Marshall G, Abernathy K, Semmens J, Hindell MA, Arnould JP.

Biol Open. 2016 Feb 12;5(3):262-71. doi: 10.1242/bio.016659.

5.

Cost-utility analysis of deep brain stimulation surgery plus best medical therapy versus best medical therapy in patients with Parkinson's: Economic evaluation alongside the PD SURG trial.

McIntosh E, Gray A, Daniels J, Gill S, Ives N, Jenkinson C, Mitchell R, Pall H, Patel S, Quinn N, Rick C, Wheatley K, Williams A; PD SURG Collaborators Group.

Mov Disord. 2016 Feb 5. doi: 10.1002/mds.26423. [Epub ahead of print]

PMID:
26846185
6.

Physiotherapy and Occupational Therapy vs No Therapy in Mild to Moderate Parkinson Disease: A Randomized Clinical Trial.

Clarke CE, Patel S, Ives N, Rick CE, Dowling F, Woolley R, Wheatley K, Walker MF, Sackley CM; PD REHAB Collaborative Group.

JAMA Neurol. 2016 Mar 1;73(3):291-9. doi: 10.1001/jamaneurol.2015.4452.

PMID:
26785394
7.

The role of high-dose myeloablative chemotherapy with haematopoietic stem cell transplantation (HSCT) in children with central nervous system (CNS) tumours: protocol for a systematic review and meta-analysis.

Main C, Wilson JS, Stevens SP, Houlton AE, English M, Kearns PR, Phillips B, Pizer B, Wilne S, Wheatley K.

Syst Rev. 2015 Nov 20;4:168. doi: 10.1186/s13643-015-0155-7.

8.

Surgical excision margins in primary cutaneous melanoma: A meta-analysis and Bayesian probability evaluation.

Wheatley K, Wilson JS, Gaunt P, Marsden JR.

Cancer Treat Rev. 2016 Jan;42:73-81. doi: 10.1016/j.ctrv.2015.10.013. Epub 2015 Nov 10. Review.

PMID:
26563920
9.

Comparing results from long and short form versions of the Parkinson's disease questionnaire in a longitudinal study.

Jenkinson C, Clarke C, Gray R, Hewitson P, Ives N, Morley D, Rick C, Wheatley K, Williams A.

Parkinsonism Relat Disord. 2015 Nov;21(11):1312-6. doi: 10.1016/j.parkreldis.2015.09.008. Epub 2015 Sep 3.

PMID:
26360237
10.

Impact of gender on efficacy and acute toxicity of alkylating agent -based chemotherapy in Ewing sarcoma: secondary analysis of the Euro-Ewing99-R1 trial.

van den Berg H, Paulussen M, Le Teuff G, Judson I, Gelderblom H, Dirksen U, Brennan B, Whelan J, Ladenstein RL, Marec-Berard P, Kruseova J, Hjorth L, Kühne T, Brichard B, Wheatley K, Craft A, Juergens H, Gaspar N, Le Deley MC; Euro-EWING99 Group.

Eur J Cancer. 2015 Nov;51(16):2453-64. doi: 10.1016/j.ejca.2015.06.123. Epub 2015 Aug 10.

PMID:
26271204
11.

Identification of Prey Captures in Australian Fur Seals (Arctocephalus pusillus doriferus) Using Head-Mounted Accelerometers: Field Validation with Animal-Borne Video Cameras.

Volpov BL, Hoskins AJ, Battaile BC, Viviant M, Wheatley KE, Marshall G, Abernathy K, Arnould JP.

PLoS One. 2015 Jun 24;10(6):e0128789. doi: 10.1371/journal.pone.0128789. eCollection 2015.

12.

Costs and quality of life associated with acute upper gastrointestinal bleeding in the UK: cohort analysis of patients in a cluster randomised trial.

Campbell HE, Stokes EA, Bargo D, Logan RF, Mora A, Hodge R, Gray A, James MW, Stanley AJ, Everett SM, Bailey AA, Dallal H, Greenaway J, Dyer C, Llewelyn C, Walsh TS, Travis SP, Murphy MF, Jairath V; TRIGGER investigators.

BMJ Open. 2015 Apr 29;5(4):e007230. doi: 10.1136/bmjopen-2014-007230.

13.

Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement.

Stewart LA, Clarke M, Rovers M, Riley RD, Simmonds M, Stewart G, Tierney JF; PRISMA-IPD Development Group.

JAMA. 2015 Apr 28;313(16):1657-65. doi: 10.1001/jama.2015.3656.

PMID:
25919529
14.

An occupational therapy intervention for residents with stroke related disabilities in UK care homes (OTCH): cluster randomised controlled trial.

Sackley CM, Walker MF, Burton CR, Watkins CL, Mant J, Roalfe AK, Wheatley K, Sheehan B, Sharp L, Stant KE, Fletcher-Smith J, Steel K, Wilde K, Irvine L, Peryer G; OTCH trial investigators.

BMJ. 2015 Feb 5;350:h468. doi: 10.1136/bmj.h468.

15.

Systematic review and meta-analysis of hydrocarbon exposure and the risk of Parkinson's disease.

Palin O, Herd C, Morrison KE, Jagielski AC, Wheatley K, Thomas GN, Clarke CE.

Parkinsonism Relat Disord. 2015 Mar;21(3):243-8. doi: 10.1016/j.parkreldis.2014.12.017. Epub 2014 Dec 26. Review.

16.

Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers Initiative.

Bogaerts J, Sydes MR, Keat N, McConnell A, Benson A, Ho A, Roth A, Fortpied C, Eng C, Peckitt C, Coens C, Pettaway C, Arnold D, Hall E, Marshall E, Sclafani F, Hatcher H, Earl H, Ray-Coquard I, Paul J, Blay JY, Whelan J, Panageas K, Wheatley K, Harrington K, Licitra L, Billingham L, Hensley M, McCabe M, Patel PM, Carvajal R, Wilson R, Glynne-Jones R, McWilliams R, Leyvraz S, Rao S, Nicholson S, Filiaci V, Negrouk A, Lacombe D, Dupont E, Pauporté I, Welch JJ, Law K, Trimble T, Seymour M.

Eur J Cancer. 2015 Feb;51(3):271-81. doi: 10.1016/j.ejca.2014.10.027. Epub 2014 Dec 24. Review.

18.

Treatment Reasons, Resource use and Costs of Hospitalisations in People with Parkinson's: Results from a Large Rct.

Xin Y, Clarke CE, Muzerengi S, Rick CE, Gray A, Gray R, Wheatley K, Ives N, McIntosh E.

Value Health. 2014 Nov;17(7):A809. doi: 10.1016/j.jval.2014.08.541. Epub 2014 Oct 26. No abstract available.

19.

Mylotarg has potent anti-leukaemic effect: a systematic review and meta-analysis of anti-CD33 antibody treatment in acute myeloid leukaemia.

Loke J, Khan JN, Wilson JS, Craddock C, Wheatley K.

Ann Hematol. 2015 Mar;94(3):361-73. doi: 10.1007/s00277-014-2218-6. Epub 2014 Oct 5. Review.

20.

Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial.

3C Study Collaborative Group, Haynes R, Harden P, Judge P, Blackwell L, Emberson J, Landray MJ, Baigent C, Friend PJ.

Lancet. 2014 Nov 8;384(9955):1684-90. doi: 10.1016/S0140-6736(14)61095-3. Epub 2014 Jul 28.

PMID:
25078310
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk